Identification, screening and antibacterial application of an antimicrobial peptide from sturgeon testis protein
By extracting and purifying peptides NDEELNKLM and RSSKRRQ from sturgeon sting protein, verifying their antibacterial activity and exploring the antibacterial mechanism, the shortcomings of antibacterial peptide research in sturgeon sting tissue were solved, and effective inhibition of Gram-positive bacteria was achieved. Supported by the study of the screening and structure-activity relationship of high-efficiency antimicrobial peptides from fish sources.
Patent Information
- Application Number
- CN202310659268.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-06-06
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2043-06-06
AI Technical Summary
The existing technology is difficult to effectively utilize antimicrobial peptides in sturgeon sperm tissue, and there are few studies on inhibitory activity of Gram-positive bacteria, especially in the context of finding natural antimicrobial agents, traditional research mainly focuses on fish or toads. Histone-derived peptides found in skin mucus.
After extraction, enzymatic decomposition and purification from sturgeon, peptides NDEELNKLM and RSSKRRQ with antibacterial activity were identified and screened. The antibacterial activity was synthesised and purified by HPLC using LC-MS/MS analysis and activity prediction tools. Activity and explore its antibacterial mechanism.
The antibacterial activities of the sturgeon sperm peptide NDEELNKLM and RSSKRRQ were successfully identified and verified. Through interaction with DHFR and DNAgyrase, it inhibited the intracellular nucleic acid metabolism of E.coli, significantly improved the inhibitory effect on Gram-positive bacteria, and provided Data support for the prediction screening and structure-activity relationship of high-efficiency antimicrobial peptides in fish source.
Smart Images

Figure CN116836228B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of biopharmaceuticals, and in particular to identification and screening of antimicrobial peptides in sturgeon testis proteins and their antimicrobial application. Background Art
[0002] At present, like food safety, bacterial pneumonia is also a major public health issue worldwide. How to control its related pathogenic microorganisms is considered one of the main challenges to ensure human safety. Staphylococcus aureus and Escherichia coli are two representative Gram-positive and Gram-negative pathogens, respectively. They are common foodborne pathogens that can cause food poisoning and toxic shock syndrome. At the same time, like Pseudomonas aeruginosa, a non-fermenting Gram-negative bacillus, they are the main causes of hospital-acquired infections. In recent years, due to the adverse effects of chemical preservatives on human health and the increasing antibiotic resistance, more and more researchers are looking for natural antimicrobial agents. In this process, the emergence of low molecular weight antimicrobial peptides (AMPs) from various organisms has attracted the attention of many researchers.
[0003] AMPs are a class of highly conserved peptides that are widely present in nature. They exhibit broad-spectrum antimicrobial activity both in vivo and in vitro. All multicellular organisms have an anti-pathogen defense mechanism that can produce a variety of AMPs through the innate immune system. Fish are an important source of antimicrobial peptides because they express all major categories of AMPs, including defensins, cathelicidins, hepcidins, histone-derived peptides, etc. Histones are a class of small molecule basic proteins and are one of the components of the innate immune system. In recent years, the antimicrobial effects of histones and their derived peptide fragments have been widely studied.
[0004] Histone-derived AMPs have been identified in many fish species and have been shown to have potent antimicrobial properties with broad-spectrum activity against both human and fish pathogens. Previous studies have reported for the first time that histone H2B-like proteins isolated from catfish skin have broad-spectrum antimicrobial activity, effectively inhibiting the growth of Escherichia coli (EscherichiacoliD31), Aeromonas hydrophila, and Saprolegnia. The antimicrobial mechanism of histone-derived peptides is believed to be partly due to their membrane-penetrating activity, which kills microorganisms by entering the interior of cells to interact with nucleic acids and interfere with normal intracellular functions. Currently, more studies are on histone-derived peptides with antimicrobial activity found in the skin mucus of fish or toads, and there are few studies on the antimicrobial activity of histones from fish sperm tissue. Summary of the invention
[0005] The present invention aims to solve the above technical problems and provides the identification and screening of antimicrobial peptides obtained by enzymolysis and purification of sturgeon spermatogonia protein extract as raw material and its antimicrobial application.
[0006] In order to solve the above technical problems, the technical solution provided by the present invention is:
[0007] The invention discloses an antimicrobial peptide in sturgeon testis protein, comprising NDEELNKLM, RSSKRRQ or a mixture of the two. The sturgeon testis is used as a raw material, and is subjected to enzymatic hydrolysis and purification to obtain sturgeon testis peptides. The amino acid sequence of the sturgeon testis peptides is analyzed and identified by LC-MS / MS. Meanwhile, target peptides NDEELNKLM and RSSKRRQ with good antimicrobial activity potential are screened out by means of an activity prediction tool and an antimicrobial peptide database. The target peptides are artificially synthesized, purified by HPLC, and characterized by electrospray ionization mass spectrometry to obtain artificially synthesized peptides with a purity of more than 95%.
[0008] Preferably, the steps for preparing the sturgeon peptide are as follows:
[0009] S1, dissolving sturgeon testis tissue in distilled water at a solid-liquid ratio of 1:50 g / mL, adding 0.65% w / v papain, reacting at pH 7 and 37° C. for 6 h to obtain an enzymolyzate;
[0010] S2, the hydrolysate was boiled for 10 min to stop the reaction, and then cooled to room temperature in an ice bath. The hydrolysate was centrifuged at 2000 × g for 20 min at 4 °C, and the supernatant was collected;
[0011] S3, the supernatant was filtered through a 0.22 μm filter membrane, and the peptide was purified by high-resolution gel filtration using a protein purification system, using a mobile phase of 20 mmol / L PBS buffer at pH 7.0 for elution, a flow rate of 0.5 ml / min, and a detection wavelength of 220 nm to collect all sturgeon peptide liquids containing the target peptide;
[0012] S4. The sturgeon peptide liquid is freeze-dried to obtain peptide powder.
[0013] Preferably, the target peptide has more than 5 amino acids.
[0014] Preferably, the amino acid sequence of sturgeon peptide is identified by reducing and alkylating the sample with dithiothreitol and iodoacetamide respectively, then dissolving the sample in a dissolving solution of 0.1% formic acid and 5% acetonitrile, subjecting the sample to chromatographic separation using a chromatographic system with a nanoliter flow rate, the sample enters a chromatographic analysis column, and after peptide segment separation, mass spectrometry analysis is performed using a mass spectrometer, and manual de novo sequencing is performed using a search engine, and the peptides obtained by de novo sequencing analysis are identified and matched with reference to a protein database, and all identified peptides are compared through the CAMPR4 website, and the comparison results with higher scores and lower E-values are selected.
[0015] Preferably, the chromatographic conditions of the chromatographic analysis column are as follows: within 40 min, the flow rate is 500 nL / min; the gradient of mobile phase A is 0-3 min, 95-90%; 3-4.5 min, 90-72%; 4.5-28 min, 72-60%; 28-40 min, 60%-0%; the gradient of mobile phase B is 0-3 min, 3%; 3-4.5 min, 3-8%; 4.5-28 min, 8-32%; 28-31 min, 32-44%; 31-34 min, 44-99%; 34-40 min, 99%.
[0016] The invention discloses an antimicrobial peptide in sturgeon testis protein, which has antimicrobial activity and inhibition for preparing a drug for treating gram-positive bacteria.
[0017] Preferably, the antimicrobial activity is determined by broth microdilution of the synthetic peptide.
[0018] Preferably, the broth microdilution method is to use MHB medium to culture at 37°C and 60r / min for 16-24h to make the viable count reach about 10 7 CFU / mL, the synthetic peptide was diluted 2-fold in a 96-well plate using MHB, the control group contained only 100 μL MHB, 1 μL of E. coli suspension was added to each well, and cultured at 37°C for 24 h. The absorbance was detected at 600 nm using an ELISA reader, and the inhibition rate of the synthetic peptide on E. coli was calculated according to the IC 50 .
[0019] Preferably, the concentration of the artificial synthetic peptide is 10000, 5000, 2500, 1250, 625, 312.5, 156.25 to 0 μg / mL, respectively.
[0020] After adopting the above formula or steps, the present invention has the following advantages:
[0021] The invention uses sturgeon testis protein extract as raw material, obtains sturgeon sperm peptide after enzymatic hydrolysis and purification, and uses LC-MS / MS to analyze and identify the amino acid sequence of sturgeon sperm peptide. With the help of activity prediction tools and antimicrobial peptide database, target peptides with good antimicrobial activity potential are screened out. The target peptide is artificially synthesized, its antimicrobial activity is verified and its antimicrobial mechanism is further clarified. Data support is provided for the prediction and screening of fish-derived high-efficiency antimicrobial peptides and the study of structure-activity relationship.
[0022] The present invention screens two new peptides NDEELNKLM and RSSKRRQ with antibacterial activity from the identified peptide segments through virtual screening and molecular docking. They can interact with DHFR and DNAgyrase through the formation of salt bridges and hydrogen bonds. When they are mixed in equal concentrations and proportions, they have the best antibacterial effect on E. coli. NDEELNKLM and RSSKRRQ can cause changes in bacterial membrane permeability and reduce cell activity. They can enter the interior of the cell and inhibit the nucleic acid metabolism process in the E. coli cell, thereby exerting an antibacterial effect.
[0023] The above summary is for illustrative purposes only and is not intended to be limiting in any way. In addition to the illustrative aspects, embodiments and features described above, further aspects, embodiments and features of the present invention will be readily apparent by reference to the full text and the following detailed description. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] Figure 1 This is a virtual screening diagram of antimicrobial peptides.
[0025] Figure 2 These are the molecular docking simulation diagrams of the peptide with DNAgyrase (A) and DHFR (B).
[0026] Figure 3 It is the antibacterial activity graph of the peptide against E. coli.
[0027] Figure 4 This is an analysis diagram of the antibacterial mechanism of NDEELNKLM and RSSKRRQ against E.coi. DETAILED DESCRIPTION
[0028] Specific embodiments of the present invention will now be mentioned in detail. Although the present invention is described in conjunction with these specific embodiments, it should be appreciated that it is not intended to limit the present invention to these specific embodiments. On the contrary, these embodiments are intended to cover substitutions, changes or equivalent embodiments that may be included in the spirit and scope of the invention defined by the claims. In the following description, a large number of specific details are set forth in order to provide a comprehensive understanding of the present invention. The present invention can be implemented without some or all of these specific details. In other cases, in order not to make the present invention unnecessarily obscure, well-known process operations are not described in detail.
[0029] When used in conjunction with "including," "methods comprising," or similar language in this specification and the appended claims, the singular forms "a," "an," and "the" include plural references unless the context clearly dictates otherwise. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.
[0030] The present invention is further described in detail below in conjunction with the full text.
[0031] Combined with Figure 1-3 , an antimicrobial peptide in sturgeon testis protein, including NDEELNKLM, RSSKRRQ and a mixture, wherein the sturgeon testis is used as a raw material, and the sturgeon testis is enzymatically hydrolyzed and purified to obtain the sturgeon testis peptide, and the amino acid sequence of the sturgeon testis peptide is analyzed and identified by LC-MS / MS, and the target peptides NDEELNKLM and RSSKRRQ with good antimicrobial activity potential are screened out by means of activity prediction tools and antimicrobial peptide database, and the target peptides are artificially synthesized, purified by HPLC, and characterized by electrospray ionization mass spectrometry to obtain an artificially synthesized peptide with a purity of more than 95%. Sturgeon testis tissue was purchased from Hubei Qingjiang Xunlong Fishery Co., Ltd. Papain was purchased from Sinopharm Chemical Reagent Co., Ltd. Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa were obtained from the China Center for Type Culture Collection. Luria-BertaniBroth (LB) and Mueller-HintonBroth (MHB) culture media were purchased from Haibo Biotechnology Co., Ltd. The reagents used for liquid chromatography and mass spectrometry were all chromatographic grade reagents purchased from SigmaAldrichChemical. All other chemicals and reagents were of analytical grade and purchased commercially.
[0032] The preparation steps of sturgeon peptide are as follows:
[0033] S1, dissolving sturgeon testis tissue in distilled water at a solid-liquid ratio of 1:50 g / mL, adding 0.65% w / v papain, reacting at pH 7 and 37° C. for 6 h to obtain an enzymolyzate;
[0034] S2, the hydrolysate was boiled for 10 min to stop the reaction, and then cooled to room temperature in an ice bath. The hydrolysate was centrifuged at 2000 × g for 20 min at 4 °C, and the supernatant was collected;
[0035] S3, the supernatant was filtered through a 0.22 μm filter membrane, and the peptide was purified by high-resolution gel filtration using a protein purification system, using a mobile phase of 20 mmol / L PBS buffer at pH 7.0 for elution, a flow rate of 0.5 ml / min, and a detection wavelength of 220 nm to collect all sturgeon peptide liquids containing the target peptide;
[0036] S4. The sturgeon peptide liquid is freeze-dried to obtain peptide powder.
[0037] The target peptide has more than 5 amino acids.
[0038] The amino acid sequence of the sturgeon peptide is identified by reducing and alkylating the sample with dithiothreitol and iodoacetamide respectively, then dissolving the sample in a dissolving solution of 0.1% formic acid and 5% acetonitrile, performing chromatographic separation on the sample using a chromatographic system with a nanoliter flow rate, and the sample enters a chromatographic analysis column. After the peptide segments are separated, mass spectrometry analysis is performed using a mass spectrometer, and manual de novo sequencing is performed using a search engine, and the peptides obtained by de novo sequencing analysis are identified and matched with reference to a protein database, and all identified peptides are compared through the CAMPR4 website, and comparison results with higher scores and lower E-values are selected.
[0039] The chromatographic conditions of the chromatographic analysis column are as follows: within 40 minutes, the flow rate is 500nL / min; the gradient of mobile phase A is 0-3min, 95-90%; 3-4.5min, 90-72%; 4.5-28min, 72-60%; 28-40min, 60%-0%; the gradient of mobile phase B is 0-3min, 3%; 3-4.5min, 3-8%; 4.5-28min, 8-32%; 28-31min, 32-44%; 31-34min, 44-99%; 34-40min, 99%.
[0040] The invention discloses an antimicrobial peptide in sturgeon testis protein, which has antimicrobial activity and inhibition for preparing a drug for treating gram-positive bacteria.
[0041] The antimicrobial activity of the synthetic peptides was determined by the broth microdilution method.
[0042] The broth microdilution method is to use MHB medium to culture at 37°C and 60r / min for 16-24h until the viable count reaches about 10 7 CFU / mL, the synthetic peptide was diluted 2-fold in a 96-well plate using MHB, the control group contained only 100 μL MHB, 1 μL of E. coli suspension was added to each well, and cultured at 37°C for 24 h. The absorbance was detected at 600 nm using an ELISA reader, and the inhibition rate of the synthetic peptide on E. coli was calculated according to the IC 50 .
[0043] The concentrations of the artificial synthetic peptides are 10000, 5000, 2500, 1250, 625, 312.5, 156.25 to 0 μg / mL respectively.
[0044] Preparation of peptides: Prepared according to the method described above. Then, the peptide was dissolved in distilled water at a solid-liquid ratio (g / mL) of 1:50, 0.65% (w / v) papain was added, pH was controlled at 7, and the reaction was carried out at 37°C for 6 hours.
[0045] The hydrolysate was boiled for 10 min to stop the reaction and cooled to room temperature in an ice bath. The hydrolysate was centrifuged at 2000×g for 20 min at 4°C, and part of the supernatant was collected and stored at -20°C until the next analysis.
[0046] Another portion of the supernatant was filtered through a 0.22 μm filter membrane and purified using a Bio-Rad NGCQuest equipped with Superdex Peptide 10 / 300 GL. TM The peptide was purified by high-resolution gel filtration using the 10Plus protein purification system. The mobile phase was 20mmol / L PBS buffer (pH7.0) with a flow rate of 0.5ml / min and a detection wavelength of 220nm. All sturgeon peptide liquid containing the target peptide was collected, one part was stored at -20℃ for the next analysis, and the other part was freeze-dried to obtain peptide powder.
[0047] Amino acid sequence identification of peptides: Before LC-MS / MS analysis, the samples were reduced and alkylated with dithiothreitol and iodoacetamide, respectively, and then dissolved in a dissolving solution (0.1% (v / v) formic acid (FA), 5% (v / v) acetonitrile (ANC)). The samples were chromatographically separated using a ThermoEasynLC chromatography system with a nanoliter flow rate. The samples entered the chromatographic analysis column (AcclaimPepMapRSLCC18, 2μm, 75μm×150mm), and the chromatographic conditions were as follows: within 40min, the flow rate was 500nL / min. The gradient of mobile phase A is 0-3min, 95-90%; 3-4.5min, 90-72%; 4.5-28min, 72-60%; 28-40min, 60%-0%; the gradient of mobile phase B (0.1% FA, 80% ANC) is 0-3min, 3%; 3-4.5min, 3-8%; 4.5-28min, 8-32%; 28-31min, 32-44%; 31-34min, 44-99%; 34-40min, 99%.
[0048] After peptide separation, mass spectrometry analysis was performed using a ThermoScientific Q Exactive mass spectrometer (Thermo, USA). The spray voltage and capillary temperature were set to 2.2 kV and 270 °C, respectively, the detection mode was positive ion, the parent ion scan range was 350-1550 m / z, the primary mass spectrometry resolution was 120000, the AGCtarget was 4e5, and the primary mass spectrometry MaximumIT was 50 ms. For peptide secondary mass spectrometry analysis, the secondary mass spectra of the 20 highest intensity parent ions were triggered after each full scan, the secondary mass spectrometry resolution was 50000, the AGCtarget was 1e5, the secondary MaximumIT was 100 ms, and the Normalizedcollisionenergy was 32.
[0049] Manual de novo sequencing was performed using the PEAKS Studio 10.0 search engine, with the following parameters: peptide tolerance limit of 15.0 ppm and 0.03 Da, Precursor Mass Search Type: monoisotopic, Max Missed Cleavages: 100, Digest Mode: Unspecific, Fixed Modifications: Carbamidomethylation: 57.02, Variable Modifications: Acetylation (N-term): 42.01, Oxidation (HW): 15.99, Max Variable PTM Per Peptide: 3. The peptides obtained from the de novo sequencing analysis were identified and matched with reference to the protein database Uniprot. At the same time, all identified peptides were compared through the CAMPR4 website, and the comparison results with higher scores and lower E-values were selected.
[0050] Further screening of peptides: peptides with less than or equal to 5 amino acids were eliminated, and the remaining peptides were all the peptides to be screened (including two parts: analysis results based on de novo sequencing and search and identification results based on the database). First, CPPpred was used to predict the potential of the peptide to penetrate cells, and its theoretical cell penetration activity was expressed as a calculated score value. The higher the score, the greater the potential. In order to reduce the probability of false positives, the CPPpred score threshold was set to greater than 0.7. Since the CPPpred score of all peptides identified based on the database search was less than 0.7, this step was skipped. After that, the peptides filtered in the previous step were further screened based on the CAMPR4 prediction tool (SupportVectorMachine and RandomForest algorithms), and filtered according to the conditions of SupportVectorMachine score greater than 0.5 and RandomForest score greater than 0.45. At the same time, the ToxinPred website was used to calculate the physicochemical properties of the candidate peptides and predict their toxicity.
[0051] Molecular docking analysis of peptides: The two-dimensional (2D) structures of the peptides obtained by virtual screening were predicted using the ChemDraw 20.0 software package, and then their three-dimensional (3D) structures were generated by energy minimization. The X-ray structures of DNA gyrase (DNA gyrase) and dihydrofolate reductase (DHFR) were obtained from the protein database of the Research Collaboratory for Structural Biology, and their PDB codes were 6RKS and 7REG, respectively. The peptides were selected as ligands and the two key enzymes as receptors. The positions of the ligands in the X-ray structures of DHFR and DNA gyrase were used as binding sites for molecular docking analysis. The small molecule ligands bound to the two key enzymes themselves were removed with hydrogen atoms using PyMol. AutoDock Vina was used to perform multi-to-multi molecular docking analysis on the peptides. The docking process adopted a flexible docking mode, and the side chains of the amino acids in the binding pocket could be optimized and adjusted according to the ligand conformation. According to the docking results, peptides with binding energies less than -5.5 kcal / mol with DNA gyrase and DHFR were selected and analyzed in the next step. The interaction between the ligand peptide and the two receptor enzyme molecules was analyzed by LigPlot+, and the best binding mode was selected for visualization analysis using PyMol.
[0052] (Artificially synthesized peptides) Synthesis of new peptides: The peptides obtained by the molecular docking screening were artificially synthesized by solid phase synthesis method. After purification by HPLC, the peptides were characterized by electrospray ionization mass spectrometry (ESI-MS) to ensure that the purity was above 95%.
[0053] Antimicrobial activity of new peptides: The antimicrobial activity of synthetic peptides was determined by conventional broth microdilution method. Briefly, E. coli was cultured in MHB medium at 37°C and 60 rpm for 16-24 hours until the viable count reached about 10 7 CFU / mL. The synthetic peptide was diluted in a 2-fold gradient using MHB in a 96-well plate to a final concentration of 10000, 5000, 2500, 1250, 625, 312.5, 156.25...0 μg / mL. The control group contained only 100 μMHB. Subsequently, 1 μL of the E. coli suspension was added to each well, and after incubation at 37°C for 24 hours, the absorbance was detected at 600 nm using an enzyme reader. The inhibition rate of the synthetic peptide on E. coli was calculated according to formula (1) and the IC was calculated by nonlinear fitting 50 .
[0054] Effect of the novel peptides on the membrane potential of E. coli: As described in the antibacterial activity assay of the novel peptides, the synthetic peptides were dissolved in sterile MHB (filtered with a 0.22 μm filter) and E. coli were cultured at 60 rpm and 37°C for 12 h. The same volume of MHB was used as a control. After the incubation, the bacterial suspension was centrifuged at 2000 g for 5 min and washed twice with 0.1 M PBS (pH 7.4). Subsequently, 20 μL of the fluorescent probe bis-(1,3-dibutylbarbituricacid)trimethineoxonol (5 μM, DiBAC4 (3); Molecular Probes, Solarbio, Beijing, China) and 180 μL of the bacterial suspension were added to a black opaque 96-well plate (Nunc, Copenhagen, Denmark). After incubation at 37°C in the dark for 15 min, the fluorescence intensity was measured using a microplate reader at 490 nm excitation / 525 nm emission wavelength.
[0055] Effect of the new peptide on the activity of E. coli cells: E. coli cells were collected, the bacterial suspension was centrifuged at 2000g for 5 minutes, washed twice with 0.1M PBS (pH7.4) and resuspended. 100 μL of the resuspension and 10 μL of propidium iodide (PI) fluorescent dye (50 μg / mL, PI) were added to a black opaque 96-well plate and incubated at 37°C in the dark for 6 hours. Then 1 drop of the suspension was transferred to a glass slide and observed using a fluorescent inverted microscope (IX73, Olympus, Tokyo, Japan). At the same time, the fluorescence intensity was measured using an ELISA reader at 535 nm excitation / 617 nm emission wavelength.
[0056] Analysis of the localization of new peptides in E. coli: The synthetic peptides were labeled with FITC. The FITC-labeled peptides were dissolved in sterile water, and the final concentration of a single peptide was 125 μg / mL. The two peptides were mixed in equal proportions to make their final concentrations 62.5 μg / mL. E. coli was cultured, and the FITC-labeled peptides were added to the bacterial suspension of 107 CFU / mL, and cultured at 37°C for 3 hours. The bacteria were collected by centrifugation, washed twice with 0.1 M PBS (pH 7.4), and the supernatant was discarded. Fix with 4% paraformaldehyde for 30 minutes, centrifuge at 2000g for 3-5 minutes, and the supernatant was discarded. Mix with 400 μL ADI and 100 μL PBS, place in the dark for 10-15 minutes, and then wash twice with PBS and resuspend. One drop of bacterial solution was added to a glass slide, and after sealing and fixing, it was observed with a laser confocal microscope (LSCM) (EclipseTi, Nikon, Tokyo, Japan) to analyze the localization of the peptides in E. coli cells.
[0057] Statistical analysis: All experiments were repeated in triplicate to ensure the credibility of the data. Experimental data are expressed as mean ± standard deviation, and the data were processed by SPSS software. One-way ANOVA and Duncan test were used to compare the differences between groups, and the differences were considered significant when p < 0.05. Origin was used to calculate IC using nonlinear fitting based on the Logistic function 50
[0058] The identification of sturgeon peptide is shown in the following table:
[0059] Table 1 Histone information of sturgeon peptides identified by LC-MS / MS and matched
[0060]
[0061]
[0062] Table 2 Comparison results of identified peptides based on CAMPR4 database
[0063]
[0064]
[0065] Gram–ve: indicates Gram-negative, Gram+ve: indicates Gram-positive.
[0066] Sturgeon sperm peptides were identified using LC-MS / MS technology, and the proteins matched were mainly histones of A.ruthenus (Table 1). Sturgeon sperm peptides contain fragments of different histones (H1, H2A, H2B, H4), with the highest coverage being histone H2B (45%), followed by H2A (35%), but the latter had the highest score (Table 1). Papain is a specific proteolytic enzyme that can hydrolyze the carboxyl termini of arginine and lysine in proteins and peptides, and can preferentially hydrolyze amino acids with larger hydrophobic side chains at the P2 position, and the P1′ position does not accept valine. Studies have isolated six histone-derived peptides of the H2A family from the leukocytes of Russian sturgeon, two of which have N-terminal acetylated fragments that have been shown to have good antibacterial activity and can effectively inhibit E.coliML35p, L.monocytogenesEGD,
[0067] Growth of methicillin-resistant S. aureus AATCC 33591 and C. albicans.
[0068] In order to explore potential antimicrobial peptide fragments, the identified peptides were compared based on the CAMPR4 database. The results (Table 2) showed that the three peptides KESYAIY, NSFVNDIFE, and YNKRSTITS in A.ruthenus histone H2B were identical to the fragments in R.schlegelii histone H2B, which were shown to have antibacterial activity against E.coli. At the same time, the eight peptides NDEELNK, NDEELNKL, NDEELNKLM, NDEELNKLMG, GVLPNIQ, GGVLPNIQ, GGVLPNIQA, and IAQGGVLPNIQ in H2A were identical to the fragments in L.vannamei histone H2B, and the latter was shown to have antibacterial activity against Gram-positive bacteria.
[0069] Micrococcus luteus has antimicrobial activity.
[0070] Virtual screening of new peptides: Figure 1 As shown in the figure, A and B respectively represent the virtual screening results of antimicrobial peptides in peptides identified based on de novo sequencing analysis and database search. The arc diagram is the virtual screening process, which runs step by step from the outside of the arc to the inside according to the screening conditions, and the numerical value represents the number of peptides filtered at each step. The right side of the arc diagram shows the physicochemical properties and toxicity prediction of the candidate peptides finally screened out. SequenceBLAST indicates the number of peptides after alignment based on the CAMPR4 database. Figure C shows the molecular docking score heat map of the screened candidate peptides and two receptor proteins (6RKS and 7REG), and the numerical value in the figure represents the binding energy (kcal / mol).
[0071] Some antimicrobial peptide databases and prediction tools have been gradually developed. These computer prediction tools can help large-scale screening and evaluation of new antimicrobial peptides. This paper uses two servers and three algorithms to predict potential antimicrobial peptides. The prediction results of CPPpred ( Figure 1 A) shows that only 37 of the sturgeon peptides analyzed based on de novo sequencing have a score greater than 0.7, which are more likely to have the potential to become cell-penetrating peptides. The CPPpred scores of sturgeon peptides identified based on database search are all less than 0.7 Figure 1 B). The prediction results of CAMPR4 showed that there were still 11 peptides in the sturgeon peptides based on de novo sequencing analysis whose Support Vector Machine and Random Forest scores were greater than 0.5 and 0.45 respectively ( Figure 1 A). At the same time, among the sturgeon peptides identified based on database search, there were 25 with RandomForest scores greater than 0.45, while only 3 peptides remained after comparison with the CAMPR4 database ( Figure 1 B).
[0072] The molecular docking method was used to analyze the interaction between 10 antimicrobial peptides and 5 pathogenic bacteria receptor proteins. The results provided effective evidence that these antimicrobial peptides are effective inhibitors of bacterial specific proteins. In this study, 14 peptides were molecularly docked with two key receptor molecules (DNAgyrase and DHFR) of E. coli, and peptides with higher antibacterial potential were further screened by the size of binding energy. The results showed that the binding energy of 14 peptides with DNAgyrase was less than -5. The binding energy of KNQLLK, KTLKLK, KYLLLK, NDEELNKLM, and RSSKRRQ with the two enzymes was less than -5, indicating that they are more likely to bind to the two receptors and may have stronger E. coli inhibitory activity. Among them, RSSKRRQ has the smallest binding energy with both enzyme molecules. Although the binding energy of NDEELNKLM with DNAgyrase is greater than that of some peptide molecules, its binding energy with DHFR is the smallest.
[0073] Molecular docking analysis of new peptides: Figure 2 As shown, the molecular surface of DNAgyrase is displayed in silver white, and the molecular surface of DHFR is displayed in brown yellow. a-1 and a-2 represent the Cartoon modes of DNAgyrase (binding state with two DNA chains) and DHFR, respectively. b-1 represents the binding mode of NDEELNKLM and RSSKRRQ on the molecular surface of DNAgyrase. b-2 represents the binding mode of NDEELNKLM and RSSKRRQ on the molecular surface of DHFR. DNAgyrase and DHFR are displayed in Surface mode, and the peptide molecules are displayed in Cartoon mode. c-1 and d-1 represent the 3D binding mode of NDEELNKLM and DNAgyrase, respectively, and c-2 and d-2 represent the 3D binding mode of RSSKRRQ and DHFR, respectively. DNAgyrase and DHFR are displayed in Cartoon mode, and their residues are displayed in brown yellow and dark red Sticks mode, respectively. The amino acid name and serial number of the residue are represented in black, and the peptide molecules are displayed in cyan Sticks mode. The yellow dotted line represents hydrogen bond, and the red dotted line represents salt bridge. The numbers indicate the length of hydrogen bonds. The amino acid names and numbers of the polypeptide molecules are shown in red.
[0074] The binding model of NDEELNKLM and RSSKRRQ to DNAgyrase is shown in Figure 2A. NDEELNKLM has more acidic amino acids, and its GLU4, ASN6, and MET9 can form hydrogen bonds with ASN269, GLN94, and ALA117 of DNAgyrase, respectively. In addition, the hydroxyl group of ASP2 forms a salt bridge and hydrogen bond with the guanidine group of DNAgyrase residue ARG91. RSSKRRQ has more basic amino acids, and its ARG1 guanidine group forms a salt bridge with the residue ASP82 (A) in DNA gyrase. The carboxyl group of ARG1 can form hydrogen bonds with the guanidine group of DNAgyrase residue ARG121 (C) and the hydrogen atoms of the hydroxyl group of TYR122 (C). The guanidine group of ARG6 forms hydrogen bonds with the carboxyl group of DNAgyrase residue PRO79 (A). The guanidine group of ARG5 forms hydrogen bonds with DNAgyrase residues ASP498 (B), ASP500 (B), and GLU424 (B). The carboxyl groups of SER2 and SER3 can also interact with the amino groups of DNAgyrase amino acid residues by forming hydrogen bonds.
[0075] The binding model of NDEELNKLM and RSSKRRQ to DHFR is shown in Figure 2 B. The hydroxyl group of GLU4 of NDEELNKLM forms a hydrogen bond with the amino hydrogen atom of TRP23 of DHFR residue. The hydroxyl group of MET9 forms a hydrogen bond with the hydrogen atom of the hydroxyl group of SER50 of DHFR residue. The guanidine group of ARG1 of RSSKRRQ forms a salt bridge with GLU28 of DHFR residue. LYS4 of RSSKRRQ can form hydrogen bonds with ILE21 and TRP23 of DHFR residues. At the same time, the hydroxyl group of SER3 of RSSKRRQ can form a hydrogen bond with the carboxyl group of SER50 in DHFR.
[0076] Both DNAgyrase and DHFR are important enzymes involved in and regulating the intracellular nucleic acid metabolism process. Their inhibitors have been considered as effective candidate compounds for the treatment of bacterial infections. Studies have shown that inhibition of DHFR can lead to the death of some pathogenic microorganisms, including E. coli, M. tuberculosis and S. aureus, by reducing the content of cellular tetrahydrofolate and interrupting DNA synthesis. At the same time, the inhibition of DNAgyrase can cause single-strand and double-strand breaks in microbial DNA, destroying the integrity of the genome, leading to cell death. NDEELNKLM and RSSKRRQ can tightly bind to DNAgyrase and DHFR by forming salt bridges and hydrogen bonds, indicating that the inhibitory effect of these two peptides on the growth of E. coli may be mediated by the interaction between the peptides and these enzymes.
[0077] Verification of the antibacterial activity of new peptides: Figure 3A is NDEELNKLM, B is RSSKRRQ, and C is a mixed graph of RSSKRRQ and NDEELNKLM.
[0078] The antibacterial effects of the two peptide molecules mentioned above were further verified after artificial synthesis. Figure 3 AC results showed that both NDEELNKLM and RSSKRRQ could effectively inhibit the growth of E.coli, among which NDEELNKLM had a stronger inhibitory effect on E.coli. At the same time, the inhibitory effect of the mixed peptide of NDEELNKLM and RSSKRRQ on E.coli was significantly better than that of either alone, and its IC50 was nearly 10 times lower than that of NDEELNKLM. Many histone-derived peptides from aquatic animals have been widely studied and applied. For example, BuforinI was isolated from the stomach tissue of the Asian toad Bufobufogargarizans, and BuforinII was produced by the hydrolysis of BuforinI. They are both peptide fragments of histone H2A, and both have been shown to have strong broad-spectrum antibacterial activity. In addition, ParasinI, a histone-derived peptide with broad-spectrum antibacterial activity isolated from the skin of injured catfish, is also the precursor of histone H2A. A study has shown that the presence of the N-terminal basic amino acid residue of ParasinI is crucial for its membrane binding activity. In this study, NDEELNKLM with high antibacterial activity also originated from histone H2A. However, its amino acid sequence is quite different from that of BuforinI and ParasinI, and it has more acidic amino acids, which suggests that it may be a histone-derived peptide.
[0079] The antibacterial activity of protamine is mostly derived from the abundant arginine or lysine in its sequence, but whether its hydrolysate still has antibacterial activity has rarely been studied. Iohara et al. found that the peptide VSRRRRRRGGRRRR isolated from protamine had antifungal activity against C.albicans. Jun-ichi Nagao et al. cyclized the protamine hydrolyzed peptide through a disulfide bond (CRRRRRRGGRRRRC) and found that it had higher antifungal activity against C.albicans. Studies have shown that small molecule cationic peptides also have the potential to become antibacterial peptides. A net charge of +4 is sufficient to make a 9-amino acid peptide produce antibacterial activity. At the same time, they may have a special mechanism of action different from that of large molecular peptides. In this study, RSSKRRQ is rich in arginine, and its net charge is +4 ( Figure 1 A), so we speculated that it might act as a cationic short peptide to inhibit the growth of E. coli.
[0080] Analysis of the antibacterial mechanism of new peptides: Figure 4As shown, A is E.co / i membrane potential analysis, BC is E.coli cell activity analysis, and D is peptide localization analysis. The horizontal axis concentration in A and B represents the final concentration of the mixed peptide, and * indicates that the fluorescence intensity is significantly different from the Control group (p<0.05). In C, a, b, c, and d represent the concentrations of the mixed peptides of 20, 50, 100, and 500 μg / mL, respectively. In A, B, and C, the control group does not contain peptides. D represents LSCM images of E.co / i treated with different peptides (green: FITC, blue: DAPI), a: NDEELNKLM, b: RSSKRRQ, c: NDEELNKLM mixed with RSSKRRQ. The image scale bar is 10 μm.
[0081] Since the mixed peptide of NDEELNKLM and RSSKRRQ has stronger antibacterial activity, the effect on cell activity ( Figure 4 BC) and peptide localization analysis ( Figure 4 D) Further explore their antibacterial mechanism against E. coli. DiBAC4(3) and PI fluorescent dyes are often used to evaluate changes in membrane potential and cell membrane integrity, respectively. Compared with the control group, the two peptides mixed in equal proportions can significantly increase (p<0.05) the fluorescence intensity ( Figure 4 A, Figure 4 B). As the concentration increases, more red fluorescence can be observed ( Figure 4 C). The results show that the two peptides can cause depolarization of the E. coli cell membrane when acting together, causing damage to the cell membrane and thus affecting cell activity. LSCM results ( Figure 4 D) It can be seen that both NDEELNKLM and RSSKRRQ entered the E. coli cells and bound to their DNA. Previous studies have shown that BuforinII exerts its antibacterial effect by penetrating the cell membrane and interacting with intracellular targets such as DNA. BuforinI and ParasinI exert their antibacterial effects by destroying the cell membrane. However, the above two antibacterial mechanisms do not exist alone. Studies have shown that some antibacterial substances, including antimicrobial peptides, may also exert their antibacterial effects through dual antibacterial mechanisms, that is, they can destroy the integrity of the cell membrane and inhibit intracellular metabolism. In this study, both NDEELNKLM and RSSKRRQ have cell membrane penetration activity and can enter the E. coli cells to exert their antibacterial effects by affecting their nucleic acid metabolism.
[0082] After identification, the proteins matched by sturgeon peptides are mainly histones of A.ruthenus, which contain fragments of histones H1, H2A, H2B, and H4. Histone H2B has the highest coverage (45%), followed by H2A (35%). Two new peptides with antibacterial activity, NDEELNKLM and RSSKRRQ, were screened from the identified peptides through virtual screening and molecular docking. They can interact with DHFR and DNAgyrase through the formation of salt bridges and hydrogen bonds. When they are mixed in equal concentrations and proportions, they have the best antibacterial effect on E.coli. Analysis of the antibacterial mechanism found that NDEELNKLM and RSSKRRQ can lead to changes in the permeability of the bacterial membrane and reduce cell activity. At the same time, they can enter the cell and inhibit the nucleic acid metabolism process in E.coli cells, thereby exerting an antibacterial effect.
[0083] The present invention and its embodiments are described above, and such description is not restrictive. What is shown in the full text is only one of the embodiments of the present invention, and the actual structure is not limited thereto. In short, if ordinary technicians in the field are inspired by it, without departing from the purpose of the invention, they can design a structure and embodiment similar to the technical solution without creativity, which should belong to the protection scope of the present invention.
Claims
1. An antimicrobial peptide from sturgeon testis protein, characterized in that: It is NDEELNKLM, RSSKRRQ or a mixture of the two.
2. Use of the antimicrobial peptide in sturgeon testis protein according to claim 1 in the preparation of a medicine having antimicrobial activity and inhibitory effect on Escherichia coli.
